News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Mike Mitchell's lab has numerous ongoing research partnerships to support new therapeutic solutions with commercial entities that were facilitated by PCI.
As the number of gene and cell therapy jobs continue to grow, Philadelphia continues to attract diverse pools of talent.
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.
Read about the current state of the biopharma industry in the face of pending patent cliff.
Penn and Carisma Therapeutics (Carisma) have strengthened the intellectual property portfolio covering this technology with the issuance of five additional patents in 2022.
Meet PCI's newest staff members and read their bios.
John Swartley and Bhavana Mohanraj discuss how working remotely will impact research and innovation hubs.
Learn about Dr. Bruce Levine's predictions for the future uses of Car-T therapy.
Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.
This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.